
CannBioRx Life Sciences Corp. – NASDAQ:ATNFW
CannBioRx Life Sciences Corp. stock price today
CannBioRx Life Sciences Corp. stock price monthly change
CannBioRx Life Sciences Corp. stock price quarterly change
CannBioRx Life Sciences Corp. stock price yearly change
CannBioRx Life Sciences Corp. key metrics
Market Cap | 3.38M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -41.58 |
Revenue | N/A |
EBITDA | -10.65M |
Income | -16.24M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCannBioRx Life Sciences Corp. stock price history
CannBioRx Life Sciences Corp. stock forecast
CannBioRx Life Sciences Corp. financial statements
Jun 2023 | 0 | -3.68M | |
---|---|---|---|
Sep 2023 | 0 | -10.26M | |
Dec 2023 | 166.03K | -1.22M | -739.09% |
Mar 2024 | 0 | -1.06M |
Jun 2023 | 13666714 | 6.95M | 50.86% |
---|---|---|---|
Sep 2023 | 4958085 | 5.10M | 103.01% |
Dec 2023 | 5259476 | 5.38M | 102.43% |
Mar 2024 | 3441740 | 4.39M | 127.73% |
Jun 2023 | -3.11M | 640.39K | 2.46M |
---|---|---|---|
Sep 2023 | -1.77M | -4.85M | 2.44M |
Dec 2023 | -2.16M | 4.21M | 1.46M |
Mar 2024 | -1.03M | 0 | -264.39K |
CannBioRx Life Sciences Corp. alternative data
Jan 2024 | 5 |
---|---|
Feb 2024 | 5 |
Mar 2024 | 5 |
Apr 2024 | 4 |
May 2024 | 4 |
Jun 2024 | 4 |
Jul 2024 | 4 |
CannBioRx Life Sciences Corp. other data
-
What's the price of CannBioRx Life Sciences Corp. stock today?
One share of CannBioRx Life Sciences Corp. stock can currently be purchased for approximately $0.41.
-
When is CannBioRx Life Sciences Corp.'s next earnings date?
Unfortunately, CannBioRx Life Sciences Corp.'s (ATNFW) next earnings date is currently unknown.
-
Does CannBioRx Life Sciences Corp. pay dividends?
No, CannBioRx Life Sciences Corp. does not pay dividends.
-
How much money does CannBioRx Life Sciences Corp. make?
CannBioRx Life Sciences Corp. has a market capitalization of 3.38M.
-
What is CannBioRx Life Sciences Corp.'s stock symbol?
CannBioRx Life Sciences Corp. is traded on the NASDAQ under the ticker symbol "ATNFW".
-
What is CannBioRx Life Sciences Corp.'s primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of CannBioRx Life Sciences Corp.?
Shares of CannBioRx Life Sciences Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does CannBioRx Life Sciences Corp. have?
As Jul 2024, CannBioRx Life Sciences Corp. employs 4 workers.
-
What is CannBioRx Life Sciences Corp.'s official website?
The official website for CannBioRx Life Sciences Corp. is 180lifesciences.com.
-
How can i contact CannBioRx Life Sciences Corp.?
CannBioRx Life Sciences Corp. can be reached via phone at +65 05070669.
CannBioRx Life Sciences Corp. company profile:

CannBioRx Life Sciences Corp.
180lifesciences.comNASDAQ
4
Medical - Pharmaceuticals
Healthcare
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Palo Alto, 94306
CIK: 0001690080
ISIN: US68236V1127
: